Component

Beta-alanine

Context-specific entity; species, compartment and exposure are stated on each claim.

16 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

Read recorded mechanisms Open recursive mind map

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. Human TauT structures captured beta-alanine and taurine as separately bound substrate analogues at the transporter binding site.

    Beta-alanine → Taurine source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Human SLC6A6 cryo-EM structures and biochemical analysis.
    limitations
    Shared binding does not prove taurine depletion at typical beta-alanine supplement exposure.
    nutrient_topic
    Taurine collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Taurine
    plain_language
    Beta-alanine and taurine interact with the same molecular doorway.
    primary_references
    Molecular basis of human taurine transporter uptake and inhibition. · 2025 · https://pubmed.ncbi.nlm.nih.gov/40789850/ · DOI 10.1038/s41467-025-62857-w

    Taurine: synthesis, transport, mitochondrial decoding and nutrient interactions (2026-09-19) · lines 129–135

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Human SLC6A6 cryo-EM structures and biochemical analysis. · source_derived_draft · unverified_draft

    ## taurine-taut-beta-alanine Beta-alanine and taurine interact with the same molecular doorway. Human TauT structures captured beta-alanine and taurine as separately bound substrate analogues at the transporter binding site. Model: Human SLC6A6 cryo-EM structures and biochemical analysis. Limitations: Shared binding does not prove taurine depletion at typical beta-alanine supplement exposure. Evidence access: Primary abstract Molecular basis of human taurine transporter uptake and inhibition. · 2025 · https://pubmed.ncbi.nlm.nih.gov/40789850/ · DOI 10.1038/s41467-025-62857-w
    Complete structured claim and evidence

  2. Beta-alanine feeding increased muscle carnosine by 58.8% after four weeks and 80.1% after ten weeks.

    Beta-alanine → Human skeletal-muscle carnosine content source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Human supplementation with muscle biopsy.
    limitations
    Response size is protocol-specific.
    nutrient_topic
    Carnosine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnosine / beta-alanyl-L-histidine
    plain_language
    The precursor can build the muscle pool over weeks.
    primary_references
    Influence of beta-alanine supplementation on skeletal muscle carnosine concentrations and high intensity cycling capacity. · 2007 · https://pubmed.ncbi.nlm.nih.gov/16868650/ · DOI 10.1007/s00726-006-0364-4

    Carnosine: synthesis, transport, carbonyl chemistry and nutrient interactions (2026-09-19) · lines 204–210

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Human supplementation with muscle biopsy. · source_derived_draft · unverified_draft

    ## carnosine-ba-loading-performance The precursor can build the muscle pool over weeks. Beta-alanine feeding increased muscle carnosine by 58.8% after four weeks and 80.1% after ten weeks. Model: Human supplementation with muscle biopsy. Limitations: Response size is protocol-specific. Evidence access: Primary abstract Influence of beta-alanine supplementation on skeletal muscle carnosine concentrations and high intensity cycling capacity. · 2007 · https://pubmed.ncbi.nlm.nih.gov/16868650/ · DOI 10.1007/s00726-006-0364-4
    Complete structured claim and evidence

  3. Beta-alanine supplementation increased cycling work at 110% maximum power alongside muscle carnosine loading.

    Beta-alanine → Human high-intensity cycling work capacity source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Human cycling and muscle-biopsy study.
    limitations
    Parallel changes do not isolate proton buffering as the sole cause.
    nutrient_topic
    Carnosine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnosine / beta-alanyl-L-histidine
    plain_language
    One trial linked loading with improved high-intensity work.
    primary_references
    Influence of beta-alanine supplementation on skeletal muscle carnosine concentrations and high intensity cycling capacity. · 2007 · https://pubmed.ncbi.nlm.nih.gov/16868650/ · DOI 10.1007/s00726-006-0364-4

    Carnosine: synthesis, transport, carbonyl chemistry and nutrient interactions (2026-09-19) · lines 212–218

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Human cycling and muscle-biopsy study. · source_derived_draft · unverified_draft

    ## carnosine-ba-work One trial linked loading with improved high-intensity work. Beta-alanine supplementation increased cycling work at 110% maximum power alongside muscle carnosine loading. Model: Human cycling and muscle-biopsy study. Limitations: Parallel changes do not isolate proton buffering as the sole cause. Evidence access: Primary abstract Influence of beta-alanine supplementation on skeletal muscle carnosine concentrations and high intensity cycling capacity. · 2007 · https://pubmed.ncbi.nlm.nih.gov/16868650/ · DOI 10.1007/s00726-006-0364-4
    Complete structured claim and evidence

  4. Beta-alanine supplementation lowered free histidine in muscle by 31.6% and plasma by 30.6%; simultaneous histidine prevented these declines.

    Beta-alanine → Human skeletal-muscle free histidine content source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Same 23-day study.
    limitations
    Physiological consequences of the declines were not established.
    nutrient_topic
    Carnosine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnosine / beta-alanyl-L-histidine
    plain_language
    Making more carnosine can draw on another amino-acid pool.
    primary_references
    Effects of Histidine and β-alanine Supplementation on Human Muscle Carnosine Storage. · 2017 · https://pubmed.ncbi.nlm.nih.gov/28106620/ · DOI 10.1249/MSS.0000000000001213

    Carnosine: synthesis, transport, carbonyl chemistry and nutrient interactions (2026-09-19) · lines 116–122

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Same 23-day study. · source_derived_draft · unverified_draft

    ## carnosine-histidine-cost Making more carnosine can draw on another amino-acid pool. Beta-alanine supplementation lowered free histidine in muscle by 31.6% and plasma by 30.6%; simultaneous histidine prevented these declines. Model: Same 23-day study. Limitations: Physiological consequences of the declines were not established. Evidence access: Primary abstract Effects of Histidine and β-alanine Supplementation on Human Muscle Carnosine Storage. · 2017 · https://pubmed.ncbi.nlm.nih.gov/28106620/ · DOI 10.1249/MSS.0000000000001213
    Complete structured claim and evidence

  5. Beta-alanine alone or with histidine increased muscle carnosine; histidine alone did not, and the combined group did not exceed beta-alanine alone.

    Beta-alanine → Human skeletal-muscle carnosine content source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Thirty adults; 23 days; BA 6 g/day, histidine 3.5 g/day or both.
    limitations
    Study exposures, not personal dosing guidance.
    nutrient_topic
    Carnosine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnosine / beta-alanyl-L-histidine
    plain_language
    More of one precursor helped; adding the other did not further raise carnosine.
    primary_references
    Effects of Histidine and β-alanine Supplementation on Human Muscle Carnosine Storage. · 2017 · https://pubmed.ncbi.nlm.nih.gov/28106620/ · DOI 10.1249/MSS.0000000000001213

    Carnosine: synthesis, transport, carbonyl chemistry and nutrient interactions (2026-09-19) · lines 108–114

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Thirty adults; 23 days; BA 6 g/day, histidine 3.5 g/day or both. · source_derived_draft · unverified_draft

    ## carnosine-histidine-loading More of one precursor helped; adding the other did not further raise carnosine. Beta-alanine alone or with histidine increased muscle carnosine; histidine alone did not, and the combined group did not exceed beta-alanine alone. Model: Thirty adults; 23 days; BA 6 g/day, histidine 3.5 g/day or both. Limitations: Study exposures, not personal dosing guidance. Evidence access: Primary abstract Effects of Histidine and β-alanine Supplementation on Human Muscle Carnosine Storage. · 2017 · https://pubmed.ncbi.nlm.nih.gov/28106620/ · DOI 10.1249/MSS.0000000000001213
    Complete structured claim and evidence

  6. In a 28-day randomized trial, beta-alanine did not significantly change measured muscle carnosine or exercise muscle pH versus placebo.

    Beta-alanine → Human exercising muscle pH source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Twenty men; 6.4 g/day; proton and phosphorus MRS.
    limitations
    Without demonstrated loading, the result cannot isolate whether added tissue carnosine would buffer exercise pH.
    nutrient_topic
    Carnosine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnosine / beta-alanyl-L-histidine
    plain_language
    Loading and buffering benefits were not demonstrated in every trial.
    primary_references
    The Effects of β-Alanine Supplementation on Muscle pH and the Power-Duration Relationship during High-Intensity Exercise. · 2018 · https://pubmed.ncbi.nlm.nih.gov/29515455/ · DOI 10.3389/fphys.2018.00111

    Carnosine: synthesis, transport, carbonyl chemistry and nutrient interactions (2026-09-19) · lines 228–234

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Twenty men; 6.4 g/day; proton and phosphorus MRS. · source_derived_draft · unverified_draft

    ## carnosine-negative-loading-ph Loading and buffering benefits were not demonstrated in every trial. In a 28-day randomized trial, beta-alanine did not significantly change measured muscle carnosine or exercise muscle pH versus placebo. Model: Twenty men; 6.4 g/day; proton and phosphorus MRS. Limitations: Without demonstrated loading, the result cannot isolate whether added tissue carnosine would buffer exercise pH. Evidence access: Primary abstract The Effects of β-Alanine Supplementation on Muscle pH and the Power-Duration Relationship during High-Intensity Exercise. · 2018 · https://pubmed.ncbi.nlm.nih.gov/29515455/ · DOI 10.3389/fphys.2018.00111
    Complete structured claim and evidence

  7. Ten weeks of beta-alanine supplementation did not change muscle taurine in this study.

    Beta-alanine → Human skeletal-muscle taurine content source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Human muscle-biopsy study.
    limitations
    Does not exclude effects under other exposures or in other species.
    nutrient_topic
    Carnosine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnosine / beta-alanyl-L-histidine
    plain_language
    A proposed precursor interaction did not cause measurable depletion here.
    primary_references
    Influence of beta-alanine supplementation on skeletal muscle carnosine concentrations and high intensity cycling capacity. · 2007 · https://pubmed.ncbi.nlm.nih.gov/16868650/ · DOI 10.1007/s00726-006-0364-4

    Carnosine: synthesis, transport, carbonyl chemistry and nutrient interactions (2026-09-19) · lines 220–226

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Human muscle-biopsy study. · source_derived_draft · unverified_draft

    ## carnosine-taurine-negative A proposed precursor interaction did not cause measurable depletion here. Ten weeks of beta-alanine supplementation did not change muscle taurine in this study. Model: Human muscle-biopsy study. Limitations: Does not exclude effects under other exposures or in other species. Evidence access: Primary abstract Influence of beta-alanine supplementation on skeletal muscle carnosine concentrations and high intensity cycling capacity. · 2007 · https://pubmed.ncbi.nlm.nih.gov/16868650/ · DOI 10.1007/s00726-006-0364-4
    Complete structured claim and evidence

What acts on it

  1. Recombinant human ABAT efficiently transaminated beta-alanine.

    Human GABA transaminase / ABAT → Beta-alanine source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Human enzyme expressed in HEK293T cells.
    limitations
    No clinical effect of changing vitamin B6 intake was established.
    nutrient_topic
    Carnosine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnosine / beta-alanyl-L-histidine
    plain_language
    A competing enzyme can divert the precursor away from peptide synthesis.
    primary_references
    Carnosine and anserine homeostasis in skeletal muscle and heart is controlled by β-alanine transamination. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27062388/ · DOI 10.1113/JP272050

    Carnosine: synthesis, transport, carbonyl chemistry and nutrient interactions (2026-09-19) · lines 124–130

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Human enzyme expressed in HEK293T cells. · source_derived_draft · unverified_draft

    ## carnosine-transamination-human-abat A competing enzyme can divert the precursor away from peptide synthesis. Recombinant human ABAT efficiently transaminated beta-alanine. Model: Human enzyme expressed in HEK293T cells. Limitations: No clinical effect of changing vitamin B6 intake was established. Evidence access: Primary abstract Carnosine and anserine homeostasis in skeletal muscle and heart is controlled by β-alanine transamination. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27062388/ · DOI 10.1113/JP272050
    Complete structured claim and evidence

  2. Recombinant human AGXT2 efficiently transaminated beta-alanine.

    Human alanine-glyoxylate aminotransferase 2 / AGXT2 → Beta-alanine source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Human enzyme expressed in HEK293T cells.
    limitations
    No clinical effect of changing vitamin B6 intake was established.
    nutrient_topic
    Carnosine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnosine / beta-alanyl-L-histidine
    plain_language
    A competing enzyme can divert the precursor away from peptide synthesis.
    primary_references
    Carnosine and anserine homeostasis in skeletal muscle and heart is controlled by β-alanine transamination. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27062388/ · DOI 10.1113/JP272050

    Carnosine: synthesis, transport, carbonyl chemistry and nutrient interactions (2026-09-19) · lines 132–138

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Human enzyme expressed in HEK293T cells. · source_derived_draft · unverified_draft

    ## carnosine-transamination-human-agxt2 A competing enzyme can divert the precursor away from peptide synthesis. Recombinant human AGXT2 efficiently transaminated beta-alanine. Model: Human enzyme expressed in HEK293T cells. Limitations: No clinical effect of changing vitamin B6 intake was established. Evidence access: Primary abstract Carnosine and anserine homeostasis in skeletal muscle and heart is controlled by β-alanine transamination. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27062388/ · DOI 10.1113/JP272050
    Complete structured claim and evidence

Where it participates (unsigned role)

  1. Human GATM transferred the amidino group of arginine to beta-alanine, producing guanidinopropionate.

    Human glycine amidinotransferase AGAT / GATM → 3-Guanidinopropionate source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary full text; Figure 4B
    experimental_model
    Recombinant human enzyme assay.
    limitations
    No competition magnitude with glycine or taurine in a living person was established.
    nutrient_topic
    Agmatine Sulfate collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Agmatine Sulfate
    plain_language
    Beta-alanine connects to the guanidino-acid network through a distinct reaction.
    primary_references
    Guanidino acid hydrolysis by the human enzyme annotated as agmatinase. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36543883/ · DOI 10.1038/s41598-022-26655-4

    Agmatine Sulfate: transport, guanidino metabolism, ion channels and cross-nutrient mechanisms (2026-09-20) · lines 204–210

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Recombinant human enzyme assay. · source_derived_draft · unverified_draft

    ## agmatine-sulfate-gatm-beta-alanine Beta-alanine connects to the guanidino-acid network through a distinct reaction. Human GATM transferred the amidino group of arginine to beta-alanine, producing guanidinopropionate. Model: Recombinant human enzyme assay. Limitations: No competition magnitude with glycine or taurine in a living person was established. Evidence access: Primary full text; Figure 4B Guanidino acid hydrolysis by the human enzyme annotated as agmatinase. · 2022 · https://pubmed.ncbi.nlm.nih.gov/36543883/ · DOI 10.1038/s41598-022-26655-4
    Complete structured claim and evidence

  2. At saturating 30 mM agonist, human alpha1 glycine-receptor activation rose faster with glycine than beta-alanine or taurine, and glycine responses decayed more slowly after removal.

    Glycine → Human alpha1 homomeric glycine receptor source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Human recombinant receptor comparison using high agonist concentrations.
    limitations
    Not equivalent to relative sedative potency after oral intake.
    nutrient_topic
    Glycine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · Glycine
    plain_language
    Related molecules activate the same receptor with different timing.
    primary_references
    Kinetic determinants of agonist action at the recombinant human glycine receptor. · 2003 · https://pubmed.ncbi.nlm.nih.gov/12679369/ · DOI 10.1113/jphysiol.2002.037796

    Glycine: supply, one-carbon allocation, receptors and cross-nutrient mechanisms (2026-09-19) · lines 202–208

    AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human recombinant receptor comparison using high agonist concentrations. · source_derived_draft · unverified_draft

    ## glycine-glyr-ligand-kinetics Related molecules activate the same receptor with different timing. At saturating 30 mM agonist, human alpha1 glycine-receptor activation rose faster with glycine than beta-alanine or taurine, and glycine responses decayed more slowly after removal. Model: Human recombinant receptor comparison using high agonist concentrations. Limitations: Not equivalent to relative sedative potency after oral intake. Evidence access: Primary abstract Kinetic determinants of agonist action at the recombinant human glycine receptor. · 2003 · https://pubmed.ncbi.nlm.nih.gov/12679369/ · DOI 10.1113/jphysiol.2002.037796
    Complete structured claim and evidence

  3. Purified chicken carnosine synthase formed ADP stoichiometrically during carnosine synthesis with MgATP.

    Chicken carnosine synthase / Carns1 → Adenosine diphosphate source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract and full-text nucleotide analysis
    experimental_model
    Chicken muscle enzyme and nucleotide analysis.
    limitations
    Use ADP rather than the older inferred AMP assignment; no clinical magnesium-depletion threshold was measured.
    nutrient_topic
    Carnosine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnosine / beta-alanyl-L-histidine
    plain_language
    The synthesis reaction spends ATP and produces ADP.
    primary_references
    Molecular identification of carnosine synthase as ATP-grasp domain-containing protein 1 (ATPGD1). · 2010 · https://pubmed.ncbi.nlm.nih.gov/20097752/ · DOI 10.1074/jbc.M109.095505

    Carnosine: synthesis, transport, carbonyl chemistry and nutrient interactions (2026-09-19) · lines 28–34

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Chicken muscle enzyme and nucleotide analysis. · source_derived_draft · unverified_draft

    ## carnosine-atp-product The synthesis reaction spends ATP and produces ADP. Purified chicken carnosine synthase formed ADP stoichiometrically during carnosine synthesis with MgATP. Model: Chicken muscle enzyme and nucleotide analysis. Limitations: Use ADP rather than the older inferred AMP assignment; no clinical magnesium-depletion threshold was measured. Evidence access: Primary abstract and full-text nucleotide analysis Molecular identification of carnosine synthase as ATP-grasp domain-containing protein 1 (ATPGD1). · 2010 · https://pubmed.ncbi.nlm.nih.gov/20097752/ · DOI 10.1074/jbc.M109.095505
    Complete structured claim and evidence

  4. Recombinant human CNDP1 hydrolyzed carnosine, with a reported Km of 1.2 mM.

    Human carnosinase 1 / CNDP1 → L-Carnosine / beta-alanyl-L-histidine source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Purified human protein expressed in CHO cells.
    limitations
    Kinetic constant is not a plasma threshold.
    nutrient_topic
    Carnosine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnosine / beta-alanyl-L-histidine
    plain_language
    A separate enzyme breaks the peptide down.
    primary_references
    Sequence identification and characterization of human carnosinase and a closely related non-specific dipeptidase. · 2003 · https://pubmed.ncbi.nlm.nih.gov/12473676/ · DOI 10.1074/jbc.M209764200

    Carnosine: synthesis, transport, carbonyl chemistry and nutrient interactions (2026-09-19) · lines 44–50

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Purified human protein expressed in CHO cells. · source_derived_draft · unverified_draft

    ## carnosine-cndp1-hydrolysis A separate enzyme breaks the peptide down. Recombinant human CNDP1 hydrolyzed carnosine, with a reported Km of 1.2 mM. Model: Purified human protein expressed in CHO cells. Limitations: Kinetic constant is not a plasma threshold. Evidence access: Primary abstract Sequence identification and characterization of human carnosinase and a closely related non-specific dipeptidase. · 2003 · https://pubmed.ncbi.nlm.nih.gov/12473676/ · DOI 10.1074/jbc.M209764200
    Complete structured claim and evidence

  5. At pH 7.4, intact carnosine quenched HNE more effectively than histidine or N-acetylcarnosine, while beta-alanine was inactive.

    L-Carnosine / beta-alanyl-L-histidine → 4-Hydroxy-2-nonenal / HNE source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Cell-free comparison.
    limitations
    This molecular comparison is not proof of supplement synergy.
    nutrient_topic
    Carnosine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnosine / beta-alanyl-L-histidine
    plain_language
    The joined peptide has properties its separate parts do not reproduce.
    primary_references
    Carnosine is a quencher of 4-hydroxy-nonenal: through what mechanism of reaction? · 2002 · https://pubmed.ncbi.nlm.nih.gov/12419310/ · DOI 10.1016/s0006-291x(02)02545-7

    Carnosine: synthesis, transport, carbonyl chemistry and nutrient interactions (2026-09-19) · lines 244–250

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Cell-free comparison. · source_derived_draft · unverified_draft

    ## carnosine-hne-intact-peptide The joined peptide has properties its separate parts do not reproduce. At pH 7.4, intact carnosine quenched HNE more effectively than histidine or N-acetylcarnosine, while beta-alanine was inactive. Model: Cell-free comparison. Limitations: This molecular comparison is not proof of supplement synergy. Evidence access: Primary abstract Carnosine is a quencher of 4-hydroxy-nonenal: through what mechanism of reaction? · 2002 · https://pubmed.ncbi.nlm.nih.gov/12419310/ · DOI 10.1016/s0006-291x(02)02545-7
    Complete structured claim and evidence

  6. Purified recombinant human CARNS1 joined beta-alanine and L-histidine to form carnosine in an ATP-containing assay.

    Human carnosine synthase / CARNS1 (ATPGD1) → L-Carnosine / beta-alanyl-L-histidine source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract and full-text enzyme methods
    experimental_model
    Human enzyme expressed in HEK293T cells.
    limitations
    An enzyme assay does not define dietary requirements.
    nutrient_topic
    Carnosine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnosine / beta-alanyl-L-histidine
    plain_language
    Two building blocks are assembled by a specific enzyme.
    primary_references
    Molecular identification of carnosine synthase as ATP-grasp domain-containing protein 1 (ATPGD1). · 2010 · https://pubmed.ncbi.nlm.nih.gov/20097752/ · DOI 10.1074/jbc.M109.095505

    Carnosine: synthesis, transport, carbonyl chemistry and nutrient interactions (2026-09-19) · lines 20–26

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Human enzyme expressed in HEK293T cells. · source_derived_draft · unverified_draft

    ## carnosine-synthesis Two building blocks are assembled by a specific enzyme. Purified recombinant human CARNS1 joined beta-alanine and L-histidine to form carnosine in an ATP-containing assay. Model: Human enzyme expressed in HEK293T cells. Limitations: An enzyme assay does not define dietary requirements. Evidence access: Primary abstract and full-text enzyme methods Molecular identification of carnosine synthase as ATP-grasp domain-containing protein 1 (ATPGD1). · 2010 · https://pubmed.ncbi.nlm.nih.gov/20097752/ · DOI 10.1074/jbc.M109.095505
    Complete structured claim and evidence

  7. AOA treatment during beta-alanine feeding raised circulating beta-alanine and muscle/heart carnosine and anserine; selective GABA-T inhibition with vigabatrin did not.

    Aminooxyacetic acid / AOA → Mouse skeletal-muscle histidine dipeptide content source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Mice; beta-alanine 0.1% in drinking water for two weeks.
    limitations
    Broad inhibitor experiment; not an intervention recommendation.
    nutrient_topic
    Carnosine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnosine / beta-alanyl-L-histidine
    plain_language
    Blocking multiple precursor-disposal routes changed tissue peptide stores.
    primary_references
    Carnosine and anserine homeostasis in skeletal muscle and heart is controlled by β-alanine transamination. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27062388/ · DOI 10.1113/JP272050

    Carnosine: synthesis, transport, carbonyl chemistry and nutrient interactions (2026-09-19) · lines 140–146

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Mice; beta-alanine 0.1% in drinking water for two weeks. · source_derived_draft · unverified_draft

    ## carnosine-transamination-block Blocking multiple precursor-disposal routes changed tissue peptide stores. AOA treatment during beta-alanine feeding raised circulating beta-alanine and muscle/heart carnosine and anserine; selective GABA-T inhibition with vigabatrin did not. Model: Mice; beta-alanine 0.1% in drinking water for two weeks. Limitations: Broad inhibitor experiment; not an intervention recommendation. Evidence access: Primary abstract Carnosine and anserine homeostasis in skeletal muscle and heart is controlled by β-alanine transamination. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27062388/ · DOI 10.1113/JP272050
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards